SCHEMBL25974745

SCHEMBL25974745

Oc1ccc(-c2nccnc2Oc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.51
▸ MAPK1 P28482 1/20 0.46
▸ MAP2K4 P45985 1/20 0.46
▸ MAPKAPK2 P49137 1/20 0.46
▸ MAPKAPK3 Q16644 1/20 0.46
▸ MAPK6 Q16659 1/20 0.46
▸ PDE10A Q9Y233 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RCE1 Q9Y256 1/20 0.40
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25341074 0.85 KIF11 (0.51) KIF11MAPK1PDE10AALDH1A1NPC1
SCHEMBL25973972 0.82 TRPV1 (0.39) PDE10ANPC1RAB9A
SCHEMBL25973903 0.82 NPC1 (0.39) ALDH1A1NPC1RAB9AMAPTATM
SCHEMBL25973973 0.81 THRB (0.41) PDE10AHPGDRAB9ASMN1; SMN2
SCHEMBL25340058 0.81 KIF11 (0.48) KIF11PDE10AALDH1A1SMN1; SMN2MAPT
SCHEMBL25341777 0.80 TRPV1 (0.38) KIF11PDE10AALDH1A1MAPTATM
SCHEMBL25375442 0.80 FEN1 (0.38) RAB9ASMN1; SMN2
SCHEMBL30519281 0.80 TRPV1 (0.38) KIF11PDE10AALDH1A1MAPTATM
SCHEMBL25974746 0.79 PDE10A (0.37) PDE10A
SCHEMBL25378460 0.79 GRM4 (0.45) PDE10AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback